BioAtla (BCAB) Change in Accured Expenses (2020 - 2026)

BioAtla's Change in Accured Expenses history runs 7 years deep, the most recent figure standing at $3.1 million for Q1 2026.

• On a quarterly basis, Change in Accured Expenses rose 45.18% year-over-year to $3.1 million in Q1 2026; TTM through Mar 2026 was $3.8 million, a 258.67% increase from a year earlier, with the FY2025 full-year figure at $2.8 million, up 120.83% from the prior year.
• Change in Accured Expenses rose to $3.1 million in Q1 2026 per BCAB's latest filing, from -$747000.0 in the prior quarter.
• Across five years, Change in Accured Expenses topped out at $8.3 million in Q2 2022 and bottomed at -$9.0 million in Q1 2024.
• The 5-year median for Change in Accured Expenses is $421000.0 (2025), against an average of $65117.6.
• Across the five-year window, Change in Accured Expenses sank 2179.49% in 2022 and soared 229.51% in 2023, its largest moves.
• Year by year, Change in Accured Expenses stood at -$735000.0 in 2022, then tumbled by 886.26% to -$7.2 million in 2023, then jumped by 56.17% to -$3.2 million in 2024, then soared by 76.49% to -$747000.0 in 2025, then jumped by 510.84% to $3.1 million in 2026.
• Per Business Quant, the three latest BCAB Change in Accured Expenses figures stand at $3.1 million (Q1 2026), -$747000.0 (Q4 2025), and $1.0 million (Q3 2025).